UNICA IRIS Institutional Research Information System

FULGHESU, ANNA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 89.559
NA - Nord America 8.574
AS - Asia 3.475
SA - Sud America 453
Continente sconosciuto - Info sul continente non disponibili 341
AF - Africa 76
OC - Oceania 28
Totale 102.506
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 87.509
US - Stati Uniti d'America 8.449
SG - Singapore 1.483
CN - Cina 1.112
UA - Ucraina 564
SE - Svezia 472
BR - Brasile 355
VN - Vietnam 261
FI - Finlandia 220
GB - Regno Unito 214
DE - Germania 198
FR - Francia 172
BD - Bangladesh 143
HK - Hong Kong 107
IN - India 83
CA - Canada 68
IE - Irlanda 58
KR - Corea 57
PK - Pakistan 47
RU - Federazione Russa 44
AR - Argentina 38
MX - Messico 28
AU - Australia 25
IQ - Iraq 21
NL - Olanda 21
TR - Turchia 21
PH - Filippine 20
ID - Indonesia 19
PL - Polonia 18
BE - Belgio 16
CO - Colombia 14
ZA - Sudafrica 14
EC - Ecuador 12
EG - Egitto 12
JP - Giappone 12
KE - Kenya 12
UZ - Uzbekistan 11
CL - Cile 10
ES - Italia 10
NG - Nigeria 10
SA - Arabia Saudita 10
JM - Giamaica 8
JO - Giordania 8
LT - Lituania 8
NP - Nepal 8
PE - Perù 8
EU - Europa 7
IR - Iran 7
MA - Marocco 7
PY - Paraguay 7
RO - Romania 7
TN - Tunisia 7
DO - Repubblica Dominicana 6
VE - Venezuela 6
BH - Bahrain 5
DZ - Algeria 4
IL - Israele 4
KZ - Kazakistan 4
MY - Malesia 4
AT - Austria 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CH - Svizzera 3
ET - Etiopia 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
PT - Portogallo 3
AL - Albania 2
AO - Angola 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
GE - Georgia 2
HR - Croazia 2
KH - Cambogia 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
GY - Guiana 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MN - Mongolia 1
MU - Mauritius 1
Totale 102.163
Salva come PNG Salva come JPEG
Città #
Cagliari 84.476
Uta 2.537
Singapore 759
Ashburn 691
Fairfield 672
San Jose 551
Woodbridge 482
Chandler 433
Houston 419
Boardman 397
Dallas 367
Wilmington 305
Nyköping 297
Jacksonville 293
Ann Arbor 287
Seattle 282
Cambridge 246
Beijing 180
Los Angeles 168
Helsinki 148
Council Bluffs 135
Santa Clara 135
Nanjing 130
Boston 113
Lauterbourg 109
Dearborn 105
Menlo Park 104
Hefei 100
The Dalles 100
Buffalo 98
Hong Kong 94
Ho Chi Minh City 81
New York 61
Hanoi 56
Shanghai 56
Seoul 54
Milan 48
San Diego 44
Chicago 42
Redwood City 36
Shenyang 34
Hebei 33
Frankfurt am Main 32
Changsha 30
Toronto 28
Guangzhou 27
Nanchang 27
Jiaxing 26
São Paulo 26
Tianjin 26
Columbus 25
Orange 24
Brooklyn 23
Rome 22
San Francisco 22
Da Nang 19
Phoenix 19
Atlanta 18
London 18
Norwalk 17
Verona 17
Washington 16
Brussels 15
Lahore 15
Orem 15
Warsaw 15
Haiphong 14
Pune 13
Stockholm 13
Florence 12
Munich 12
Zhengzhou 12
Jinan 11
Belo Horizonte 10
Dublin 10
Montreal 10
Naples 10
Denver 9
Johannesburg 9
Manchester 9
Mexico City 9
Quezon City 9
Saint Petersburg 9
Tashkent 9
Tokyo 9
Curitiba 8
Kunming 8
Nairobi 8
Redondo Beach 8
Sassari 8
Charlotte 7
Düsseldorf 7
Goiânia 7
Miami 7
Poplar 7
Thái Nguyên 7
Amman 6
Amsterdam 6
Ankara 6
Biên Hòa 6
Totale 96.585
Salva come PNG Salva come JPEG
Nome #
IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance 2.859
Is there a dose-response relationship of metformin treatment in patients with polycistic ovary syndrome? Results from a multicentric study 2.597
Stained amniotic fluid: what's new? 2.462
The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population 2.344
Il-6 serum levels and production in PCOS adolescents is related to insulin resistance 2.342
Very low dose of flutamide in the treatment of hyperandrogenism 2.315
Inflammatory response to lypopolysaccharide in mononuclear cells from polycystic ovary syndrome insulin resistant adolescent 2.311
Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome 2.052
Insulin resistance and hyperandrogenism have no substantive association with birth weight in adolescents with polycystic ovary syndrome 1.941
Ultrasound diagnosis of polycystic ovarian syndrome: current guidelines, criticism and possible update 1.898
The quantitative insulin sensitivity check index is not able to detect early metabolic alterations in young patients with polycystic ovarian syndrome 1.798
Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. 1.714
Ovulation induction in young girls with menometrorragia: a safe and effective treatment 1.692
Obesity related lipid profileand altered insulin incretion in adolescent with policystic ovary syndrome 1.689
L'ovaio nella Sindrome dell'ovaio policistico 1.655
Pathogenesis 1.422
INDICAZIONE AL PARTO CESAREO PRESSO LA CLINICA OSTETRICA E GINECOLOGICA DI CAGLIARI: SU QUALI POSSIAMO RIDURRE IL RICORSO AL PARTO CESAREO? 1.371
Dismenorrea: dalle limitazioni alla quotidianità ai dolori pelvici 1.299
ANALGESIA EPIDURALE E INCIDENZA DI TAGLIO CESAREO. 1.291
Diagnosis of metabolic disorders in women with polycystic ovary syndrome 1.270
Criteri diagnostici di PCOS: recenti evoluzioni 1.266
Ecografia in ginecologia dell'infanzia e dell'adolescenza. Testo atlante 1.254
Obesity realated lipid profile and altered insulin incretion in adolescent with PCOS 1.230
Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome 1.195
Metformin effect on ovarian ultrasoundappearance and steroidogenetic functionin normal weightnormoinsulinemic women with polycystic ovary sindrome:a randomized double blind placebo-controlledclinical trial 1.191
Influenza dei parametri antropometrici sulla risposta alla Metformina in pazienti con PCOS. 1.119
78) PITUITARY – OVARIAN RESPONSE TO GONADOTROPIN- RELESING HORMONE AGONIST TEST IN ANOVULATORY PATIENTS WITH POLYCYSTIC OVARY STROMA. PREDICTIVE ROLE OF OVARIAN STROMA 1.097
null 1.083
Urinary Metabolites Reveal Hyperinsulinemia and Insulin Resistance in Polycystic Ovarian Syndrome (PCOS) 1.067
Differenze regionali nella risposta alla Metformina in pazienti con PCOS 1.024
133. Metformin effect in PCOS patients is not dose dependent 998
Diagnosi dei problemi metabolici nelle donne con PCOS 990
Ultrasound in PCOS: revisiting Rotterdam criteria 979
Endocrine and metabolic aspects in obese and lean young PCOS 968
The quantitative insulin sensitivity check index (QUICKY) is not able to detect early metabolic alterations in young patients with polycystic ovarian syndrome 921
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? 885
LA DIAGNOSI ECOGRAFICA DELLA PCOS 868
Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome. 860
Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study. 858
Ovarian stromal hypertropy and insulin abnormalities in PCOS 832
82. Pituitary-ovarian response to gonadotrpin-releasing hormone-agonist test in anovulatory patients with polycystic ovary sindrome. Predictive role of ovarian stroma 828
Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease. 796
Ovarian stroma in PCOS: relationship with circulating androgens 791
Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome. 791
Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome. Dexamethasone and GnRH-agonist administration. 789
Inositols and female reproduction disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)—Women’s Endocrinology 780
Iperinsulinemia in adolescenti affette da PCOS 773
Confronto tra autovalutazione e valutazione clinica dell’irsutismo e dell’immagine corporea in adolescenza 764
Opioid blockade effect on insulin beta-cells secretory patterns in polycystic ovary syndrome. Oral glucose load versus intravenous glucagon bolus 754
Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion. 750
Espressione genica e livelli circolanti di resistita in giovani pazienti affette da PCOS 744
null 740
null 735
Assetto lipidico in adolescenti affette da PCOS 730
Good practice in pediatric and adolescent gynecology 727
CHANGES IN LUTEINIZING HORMONE AND INSULIN SECRETION IN POLYCYSTIC OVARIAN SYNDROME 725
Ovarian stromal hypertrophy and insulin abnormalities in young PCOS 705
EFFECT OF OPIOID BLOCKADE ON INSULIN AD GROWTH HORMONE (GH) SECRETION IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME: THE HETEROGENEITY OF IMPAIRED GH SECRETION IS RELATED TO BOTH OBESITY AND HYPERINSULINISM 689
N-ACETYL-CYSTEINE TREATMENT IMPROVES THE INSULIN SENSITIVITY IN PCOS 682
INFLUENCE OF BODY MASS ON THE HYPOTHALAMIC-PITUITARY-ADRENAL-AXIS RESPONSE TO NALOXONE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME 680
Relationship between genetic and metabolic abnormalities in PCOS 668
PRECONCEPTIONAL AND GESTATIONAL EVALUATION OF INSULIN SECRETION IN PATIENTS WITH COLYCYSTIC OVARY SYNDROME 651
Knowledge of the microbiota: personal experience from 324 questionnaires administered to mother and mothers-to-be. 615
THE IMPACT OF INSULIN SECRETION ON THE OVARIAN RESPONSE TO EXOGENOUS GONADOTROPINS IN POLYCYSTIC OVARY SYNDROME 610
The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside. A Systematic Literature Review 591
ACUTE INSULIN RESPONSE TO INTRAVENOUS GLUCAGONE IN POLYCYSTIC OVARY SYNDROME 583
EVIDENCE OF A DISTINCT DERANGEMENT OF OPIOID TONE IN HYPERINSULINEMIC PATIENTS WITH POLYCYSTIC OVARY SYNDROME: RELATIONSHIP WITH INSULIN AND LUTEINIZING HORMONE 582
CORTICOTROPIN RELEASING HORMONE INDUCES AN EXAGGERATED RESPONSE OF ADRENOCORTICOTROPIC HORMONE AND CORTISOL IN POLYCYSTIC OVARY SYNDROME 572
null 565
Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome 552
An open multicenter study to compare the efficacy of intraperitoneal insemination and intrauterine insemination following multiple follicular development as treatment for unexplained infertility 533
Ultrasound in polycystic ovary syndrome--the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study 533
SOMATOSTATIN TREATMENT REDUCES THE EXAGGERATED RESPONSE OF ADRENOCORTICOTROPIN HORMONE AND CORTISOL TO CORTICOTROPIN -RELEASING HORMONE IN POLYCYSTIC OVARY SYNDROME 529
EFFECT OF OPIOID BLOCKADE ON INSULIN METABOLISM IN POLYCYSYIC OVARIAN DISEASE 524
ENDOCRINO-METABOLIC FEATURES IN WOMEN WITH POLYCYSTIC OVARY SYNDROME DURING PREGNANCY 517
Hirsutism and hyperandrogenism associated with hyperreactio luteinalis in a singleton pregnancy: a case report. 509
La clinica dei disturbi mestruali in adolescenza: risultati di un’analisi sul territorio 500
EVIDENCE OF A DISTURBANCE OF THE HYPOTALAMIC PITUITARY ADRENAL AXIS IN POLYCYSTIC OVARY SYNDROME EFFECT OF NALOXONE 491
GROWTH HORMONE ENHANCES ESTRADIOL PRODUCTION FSH INDUCED IN THE EARLY STAGE OF THE FOLLICULAR MATURATION 474
TEMPOROLIMBIC EPILEPSY AND POLYCYSTIC OVARY SYNDROME 472
Get a clear view before starting: Endometrial preparation with hormones 471
EFFECTIVENESS OF A SOMATOSTATIN ANALOGUE IN LOWERING LH AND INSULIN SECRETION IN HYPERINSULINEMIC WOMEN WITH POLYCYSTIC OVARIAN DISEASE 467
Which treatment options should be used in adolescents with polycystic ovary syndrome? 447
La clinica dei disturbi mestruali in adolescenza: risultati di un’analisi sul territorio 443
Polycystic Ovarian Morphology in Normocyclic Non-hyperandrogenic Adolescents 443
Prevalenza dei markers di autoimmunità nelle pazienti affette da preeclampsia 437
Influenza del peso sulla risposta al test all’analogo del GnRH (GnRHa) in PCOS 435
HETEROGENEITY IN ß- CELL ACTIVITY, HEPATIC INSULIN CLEARANCE AND PERIPHERAL INSULIN SENSITIVITY IN WOMEN WITH POLYCYCSTIC OVARY SYNDROME 425
Correlation of ovarian stromal hypertrophy to hyperandrogenism and insulin resistance in young women with PCOS 424
Adolescence and hyperinsulinemia: it is always the first step towards PCOS? 420
Studio osservazionale sulle irregolarità mestruali in adolescenza 417
Insulin and GH secretion in adolescent girls with irregular cycles: polycystic vs multifollicular ovaries 403
null 395
Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease. 352
A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio. 351
Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist. 338
Importance of echographic and endocrine monitoring for the assessment of ovulation by follicle stimulating hormone in polycystic ovarian disease. 337
Comment on "Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome". 333
Effect of maternal carbohydrate metabolism on fetal growth. 330
Luteal responses to gonadotropin-releasing hormone during the luteal phase: relation to the age of corpus luteum. 329
Totale 93.048
Salva come PNG Salva come JPEG
Categoria #
all - tutte 148.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.123
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.399 0 0 311 304 515 287 509 400 308 505 610 650
2022/20239.880 708 1.033 1.217 923 568 769 462 914 817 819 1.217 433
2023/202412.200 404 338 372 574 1.147 2.068 2.134 633 1.185 884 1.364 1.097
2024/202514.395 1.871 3.195 2.302 2.372 1.262 1.169 1.063 94 252 269 239 307
2025/20265.997 344 405 772 365 418 541 887 485 473 568 527 212
2026/20271.480 130 803 547 0 0 0 0 0 0 0 0 0
Totale 102.506